FIGURE 1.
Many patients with brain metastases from NSCLC will have an EGFR mutation, resulting in tumor cell survival. Determination of the tumor mutation status and response or resistance to therapy is essential in guiding treatment decisions.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.